3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
1
Graft vs Host Disease
1
Interventions
Cisplatin
15
Paclitaxel
14
Taxes
10
Cyclophosphamide
9
Carboplatin
9
Gemcitabine
7
Platinum
6
1,2-diaminocyclohexaneplatinum II citrate
6
Trastuzumab
5
Radiotherapy
5
Oxaliplatin
5
Doxorubicin
5
Docetaxel
5
Cytarabine
5
Capecitabine
5
Brachytherapy
5
fludarabine
4
Rituximab
4
Radiotherapy, Intensity-Modulated
4
Radiosurgery
4
Fluorouracil
4
Dexamethasone
4
Watchful Waiting
3
Radiotherapy, Conformal
3
Pemetrexed
3
Nimorazole
3
Lenalidomide
3
Imatinib Mesylate
3
Idarubicin
3
Gene Expression Profiling
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
NETWORK
×
trihexyltetradecylphosphonium chloride
×
Clear all
NCT05158608
2022-01-11
CY25
National Research Center for Hematology, Russia
Phase 3
Unknown
100 enrolled